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A B S T R A C T
In this work we developed new antibacterial composite materials using polydopamine (PDA) to trigger the
deposition of silver nanoparticles (AgNPs) onto calcium phosphates, namely octacalcium phosphate (OCP) and
α-tricalcium phosphate (αTCP). Functionalization of OCP and αTCP with a self-polymerized polydopamine layer
was obtained by soaking the calcium phosphates in dopamine solution. The PDA surface of functionalized
calcium phosphates (OCPd and αTCPd) promoted the deposition of AgNPs by reducing silver ions when soaked
in a silver nitrate solution. The amount of deposited AgNPs can be modulated by varying the concentration of
silver nitrate solution and the type of substrate. The results of in vitro tests carried out with osteoblast-like MG63
cells indicate that the combination of AgNPs with OCP provides more biocompatible materials than those ob-
tained using αTCP as substrate. In particular, the study of osteoblast activity and differentiation was focused on
the samples OCPdAg5 (silver content = 8.2 wt%) and αTCPdAg5 (silver content = 4.7 wt%), which did not
show any cytotoxicity, and compared with those obtained on pure OCP and αTCP. The results demonstrate that
the AgNPs loaded materials support osteoblast viability and differentiation, whereas they significantly inhibit
the growth of relevant antibiotic-resistant pathogenic bacteria.
1. Introduction
Calcium phosphates (CaPs) are widely employed for the preparation
of biomaterials for hard tissues substitution and repair, because of their
similarity to the inorganic phase of the mineralized tissues of verte-
brates. In particular, octacalcium phosphate, Ca8H2(PO4)6·5H2O (OCP),
which is considered the precursor phase of biological apatites, exhibits
osteoconductive properties and converts into hydroxyapatite (HA)
when implanted in bone defects [1]. Enhancement of bone formation
has been demonstrated both when OCP granules are used to repair bone
defects and when OCP is applied as a coating on metallic surfaces [2–6].
OCP can hydrolyze into HA in aqueous solution [7,8] However, the
process is relatively slow at physiological pH and temperature, whereas
it is accelerated at higher temperatures and in the presence of small
amount of fluoride [9–12]. Also other CaPs, in particular α-tricalcium
phosphate (αTCP), hydrolyze into HA [13]. At variance with OCP,
αTCP is considered unsuitable for surgical implants [14]; however, it is
widely employed for the preparation of calcium phosphate bone ce-
ments. αTCP has a relatively higher solubility than its polymorph,
βTCP, and the hardening reaction of αTCP containing cements implies
its conversion into HA [15,16]. One of the main problems of medical
devices, including CaPs based biomaterials, is the relatively high risk of
infections associated to their use. Silver nanoparticles (AgNPs) display
antimicrobial properties against a broad spectrum of pathogens and are
currently applied in a number of biomedical applications, including
bone cements and implant coatings [17]. We have previously developed
a fast and low cost procedure to support AgNPs on HA crystals, and
shown that the composite material displays significant, long-standing
antibacterial activity towards both S. aureus and E. coli [18]. In this
study we propose to utilize OCP and αTCP, which are more soluble and
resorbable than HA, as supports for AgNPs, using polydopamine (PDA)
as functionalizing and reducing agent. Polydopamine is a polymer
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formed under slightly basic conditions by the oxidative polymerization
of dopamine, which creates a stable layer that is adherent to the surface
of materials [19]. Stable PDA films with controlled thickness can be
deposited on virtually any substrate. Moreover, PDA is biocompatible
and exhibits several functional groups, such as catechol, amine and
imine groups, which are able to react with a wide range of molecules
[20]. In particular, the catechol group can oxidize into the corre-
sponding quinone group and trigger reduction processes of metallic
cations [21]. The peculiar characteristics of PDA prompted a number of
studies that yielded an increasing number of new applications of PDA
based materials, spanning in different fields, from energy to environ-
ment, to biomedical science [19]. Herein we optimized the experi-
mental conditions to prepare PDA functionalized OCP and αTCP at
increasing AgNPs contents, and we investigated the influence of the
presence of AgNPs on the antibacterial properties of the composite
materials against Gram positive and Gram negative reference bacterial
strains, as well as against antibiotic-resistant clinical isolates recovered
from patients with bone or prosthetic joint infections. Moreover, we
tested the ability of the materials to support in vitro growth and dif-
ferentiation of osteoblast-like cells MG63. MG63 activity and differ-
entiation were investigated using the most common markers of osteo-
blast metabolism, which were tested both on the supernatants of cell
culture and by means of quantitative Polymerase Chain Reaction
(qPCR).
2. Materials and methods
2.1. Materials synthesis and characterization
The synthesis of OCP was carried out as previously reported [22].
Briefly, 250 ml of 0.04M Ca(CH3COO)2·H2O were added dropwise into
750 ml of a phosphate solution containing 5 mmol of Na2HPO4·12H2O
and 5 mmol of NaH2PO4·H2O previously adjusted to pH 5 with
CH3COOH. The reaction was carried out at 60 °C under mechanical
stirring. After 15 min the precipitate was filtered, repeatedly washed
with distilled water and dried at 37 °C.
αTCP was obtained by solid-state reaction of a mixture of CaCO3
and CaHPO4·2H2O in the molar ratio of 1:2 at 1300 °C for 5 h [23]. The
solid product was carefully ground and sieved (< 40 μm) before being
submitted to further treatment.
Functionalization with polydopamine was obtained through im-
mersion of 100 mg of OCP or αTCP into 50 ml of a solution of dopamine
hydrochloride (2 mg/ml) at pH 8.5 (TRIS buffer), under stirring [19],
for different periods of time (1, 2 and 18 h) at room temperature. Then,
the samples were filtered, repeatedly washed with distilled water and
dried at 37 °C overnight. In the following, the samples functionalized
with PDA are indicated as OCPd and αTCPd, respectively.
Deposition of silver nanoparticles was obtained by simultaneous
addition of 20 ml of AgNO3 solution, at different concentrations (1, 5
and 10 mM), and 20 ml of a 13 mM sodium citrate solution, to the PDA
functionalized phosphates (100 mg) at room temperature under stir-
ring. After 1 h, the solid samples were filtered, repeatedly washed with
distilled water and dried at 37 °C overnight. The two series of samples
were labeled respectively OCPdAgX and αTCPdAgX, where X indicates
the concentration (mM) of AgNO3 solution.
X-ray diffraction analysis was carried out by means of a PANalytical
X'Pert PRO powder diffractometer equipped with a X'Celerator detector
(40 mA, 40 kV). For phase identification the 2θ range was investigated
from 3 to 60 2θ ° with a step size of 0.1 and time/step of 100 s.
Thermogravimetric analysis was carried out using a Perkin- Elmer
TGA-7. Heating was performed in a platinum crucible in air flow
(20 cm3/min) at a rate of 10 °C/min up to 700 °C. The samples weights
were in the range 5–10 mg. Results from this analysis represent the
mean value of determinations for three different samples of each
composition.
Morphological investigations of crystals were performed using a
Phenom ProX desktop-scanning electron microscope at beam accel-
eration voltage of 10 kV. The samples were observed as prepared and
not sputter coated before examination.
The quantification of Ag was performed using a quadrupole mass
spectrometer with plasma source ICP MS XSeries Thermo Fisher
Scientific. The samples were prepared by dissolving 10 mg of powders
in water/methanol solution 1/1 V/V. 5 ml were taken and added in
50 ml of 5% nitric acid solution.
Static contact angle measurements were performed on disk shaped
samples (Ø = 13.0 mm). Each disk was prepared by pressing 100 mg of
powder into cylindrical moulds by using a standard evacuable pellet die
(Hellma). A KSV CAM101 instrument was used under ambient condi-
tions by recording the side profiles of deionized water drops for image
analysis. The shape of the drop was recorded in a time range of 0–60 s,
by collecting an image every 0.033 s. At least six drops were observed
for each sample.
In vitro cell and antibacterial tests were performed on disk-shaped
samples (Ø = 6.0 mm). Each disk was prepared by pressing 40 mg of
powder into cylindrical moulds by using a standard evacuable pellet die
(Hellma), and sterilized using gamma rays (Cobalt-60) at a dose of
25 kGy.
AFM analysis of the disk-shaped samples was performed using a
Veeco Nanoscope 3D instrument. The samples were analyzed in tapping
mode using an E scanner (maximum scan size 15 μm) and phosphorus
(n) doped silicon probes (spring constant 20–80 N/m; resonance fre-
quency 250–290 kHz; nominal tip radius < 10 nm). Roughness para-
meters, namely arithmetic mean roughness (Ra), root-square roughness
(Rq), and the vertical distance between the highest and lowest points
within the evaluation length (Rt), were recorded.
Silver release was measured in the medium used for cell culture
differentiation (see Section 2.2.2.). The surnatants were removed from
the wells at 1, 2 and 7 days and Ag content was analyzed using a
quadrupole mass spectrometer with plasma source ICP MS XSeries
Thermo Fisher Scientific.
2.2. Cellular tests
2.2.1. Cytotoxicity tests
Human osteoblast-like cells MG63 (OB, Istituto Zooprofilattico
Sperimentale IZSBS, Brescia, Italy), were cultured in DMEM medium
(Dulbecco's Modified Eagle's Medium, Sigma, UK) supplemented with
10% FCS, and antibiotics (100 U/ml penicillin, 100 μg/ml strepto-
mycin). Cells were detached from culture flasks by trypsinization, and
cell number and viability were checked by Erythosine B dye exclusion
test. OB cells were plated at a density of 5 × 104 cells/ml in 24-well
plates containing sterile disk-shaped samples (Ø = 6.0 mm) (of the
following biomaterial: OCPdAg1, OCPdAg5, OCPdAg10, αTCPdAg1,
αTCPdAg5, αTCPdAg10. Wells for negative (CTR−, DMEM only) and
positive (CTR+, DMEM+ 0.05% phenol solution) controls were also
prepared. Plates were cultured in standard conditions, at 37 ± 0.5 °C
with 95% humidity and 5% ± 0.2 CO2 up to 72 h.
The quantitative evaluation of cytotoxicity was performed by
measuring cell viability, lactate dehydrogenase enzyme (LDH) release,
Interleukin-6 (IL-6) and Caspase 3 activity. Cell proliferation and via-
bility at 24 and 72 h was assessed by WST1 (WST1, Roche Diagnostics
GmbH, Manheim, Germany) colorimetric reagent test. The assay is
based on the reduction of tetrazolium salt into a soluble formazan salt
by a reductase of the mitochondrial respiratory chain, active only in
viable cells. 100 μl of WST1 solution and 900 μl of medium (final di-
lution: 1:10) were added to the cell monolayer, and the multi-well
plates were incubated at 37 °C for a further 4 h. Supernatants were
quantified spectrophotometrically at 450 nm with a reference wave-
length of 625nm. Results of WST1 are reported as optical density (OD)
and directly correlate with the cell number. Proliferation percent re-
lative to CTR− are also reported. At the end of experimental times the
supernatant was collected from all wells and centrifuged to remove
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particulates, if any, for LDH measure (LDH enzyme-kinetic test, Roche,
D) and IL-6 (ELISA kit. Boster Biological Technology, Ca, USA) ac-
cording to manufacture instruction. Cell lysate from all groups were
collected at 72 h for the detection of Caspase 3 activity by an im-
munoenzymatic test (Caspase-e ELISA kit, Invitrogen, CA, USA).
A qualitative analysis for cell morphology was performed by Neutral
Red (NR) vital staining. A 0.033% solution of NR staining (Sigma, UK)
in culture medium was added to each group samples at the end of ex-
perimental time, for further 90 min. Cultures were examined by optical
microscopy for the evaluation of cell morphology.
2.2.2. Bioactivity tests
OB were expanded in DMEM supplemented with 10% FCS, 1% an-
tibiotics (100 U/ml penicillin, 100 μg/ml streptomycin), β-glycer-
ophosphate (10−4 M) and Ascorbic acid (50 μg/ml), counted and
plated on material samples (OCP, OCPdAg5, αTCP, αTCPdAg5) at a
concentration of 2 × 104 cells/well in 24 wells-plates. OB were also
seeded in empty wells for control (CTR). Plates were incubated at 37 °C
in a humidified 95%air/5%CO2 atmosphere (standard condition) up to
7 days. Medium was changed with fresh medium to all wells after
3 days of culture.
2.2.2.1. Cell viability. At 7 days cell viability was observed by the Live/
Dead® assay (Molecular Probes, Eugene, OR, USA), according to the
manufacturer's instructions. Samples were visualized using an inverted
microscope equipped with an epifluorescence setup (Eclipse TiU,
NIKON Europe BV, NITAL SpA, Milan, Italy): excitation/emission
setting of 488/530 nm to detect green fluorescence (live cells) and
530/580 nm to detect red fluorescence (dead cells).
OB proliferation and viability was quantitatively evaluated by WST1
at the end of experimental time according to the method described
above.
2.2.2.2. Osteoblast activity. At the end of experimental time, after
7 days of culture, the supernatant and cell lysate were collected from
all wells. Aliquots were dispensed in Eppendorf tubes for storage at
−70 °C and assayed with the following immunoenzymatic kits:
Alkaline Phosphatase (ALP, Cloud-Clone Corp, Wuhan, China), and
Osteocalcin (OSTC, Cloud-Clone Corp), Caspase 3 (Life Technologies,
Frederick, MD, USA). All results were normalized by CTR group.
2.2.2.3. Osteoblast morphology. At the end of experimental time,
osteoblasts were fixed (2.5% glutaraldehyde in PBS pH 7.4 for 1 h),
dehydrated in a graded ethanol series, and then treated with
hexamethyldisilazane. SEM images were collected using a Hitachi S-
2400 instrument operating at 15 kV on Pd coated samples.
2.2.2.4. Quantitative Polymerase Chain Reaction (qPCR). Total RNA was
extracted from all samples at the end of experimental time using
PureLink RNA Mini Kit (Life Technologies, Carlsbad, CA, USA). Purified
RNA was reverse transcribed with Superscript VILO cDNA Synthesis kit
(Invitrogen, Life Technologies, Carlsbad, CA, USA), following
manufacturer's instructions. Each sample (10 ng) was tested in
duplicate. qPCR analysis was performed in a LightCycler Instrument
(Roche Diagnostics GmbH, Mannheim, Germany) using the QuantiTect
SYBR Green PCR kit (Qiagen, Hilden, Germany). The protocol included
a denaturation at 95 °C for 15′, 40 cycles of amplification (95 °C 15″,
appropriate annealing temperature for each target as detailed in Table
S1 for 20″ and 72 °C for 20″) and a melting curve to check for amplicon
specificity. The threshold cycle (Ct) was determined for each sample.
Relative gene expression was calculated with the 2−ΔΔCt method, using
the control samples as calibrator.
2.2.3. Statistical analysis
Statistical evaluation of data was performed using the software
package SPSS/PC+ Statistics™ 23.0 (SPSS Inc., Chicago, IL USA). The
results presented are the mean of six independent values. Data are re-
ported as mean ± standard deviations (SD) at a significance level of
p < 0.05. After having verified normal distribution and homogeneity
of variance, a one-way ANOVA was done for comparison between
groups. Finally, a post hoc multiple comparison tests was performed to
detect significant differences among groups, and Pearson test was
performed to detect correlation between data.
2.3. Bacterial strains and antibacterial susceptibility testing
The in vitro antibacterial activity of the OCPd and αTCPd samples
loaded with different amounts of Ag was evaluated against a panel of
Gram positive and Gram negative reference bacterial strains including
Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (ATCC
12228), Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC
25922), Klebsiella pneumoniae (ATCC 9591) and Pseudomonas aeruginosa
(ATCC 27853). Subsequently, having defined both the overall spectrum
of antibacterial activity and the cytotoxic profile of the tested samples,
the OCPdAg5 and αTCPdAg5 materials were assayed towards 14 clin-
ical isolates recovered from patients with bone or prosthetic joint in-
fections (7 S. epidermidis and 7 P. aeruginosa strains). Clinical strains
were isolated on BD Columbia Agar with 5% sheep blood (Becton
Dickinson, GmbH, Germany) and confirmed by MALDI-TOF MS analysis
(Bruker Daltonics, GmbH, Germany) [24]. Their antibiotic suscept-
ibility was determined by using the Vitek2 semi-automated system
(bioMerieux, France); EUCAST criteria were used for the interpretation
of results and categorization of strains (Sensitive, Intermediate or Re-
sistant strains) (www.eucast.org). Isolates resistant to ≥3 antibiotic
groups tested were considered multi-drug resistant (MDR).
The effectiveness of the composite materials to inhibit bacterial
growth was determined by means of standardized sensitivity tests based
on Kirby-Bauer (KB) diffusion method and following the procedures
established by a number of committees [25,26]. Briefly, the surface of
Mueller-Hinton agar plate (MHA) (Sigma-Aldrich) was inoculated with
the bacterial suspension at 0.5 McFarland, prepared in sterile 0.9%
saline solution and gamma rays sterilized disks (∅= 6.0 mm) were
placed on the agar plates. In compliance with the International gui-
dance documents in susceptibility testing, disks containing gentamicin
(GMN 10 μg) and/or imipenem (IPM 10 μg) (Oxoid SpA, Italy) were
included as reference controls. After 24 h of incubation at 37 °C the agar
plate was observed and the diameter of the inhibition zone (corre-
sponding to the bacterial-free zone around the disk-shaped sample) was
measured and expressed in millimeters (mm). All experiments were
performed on duplicate in different days.
3. Results and discussion
3.1. Materials characterization
The amount of PDA deposited on OCP and αTCP can be evaluated
through thermogravimetric analysis. In fact, PDA undergoes thermal
decomposition between about 250 and 650 °C, and its relative content
can be determined as difference between the total weight loss of
functionalized samples and that of the pristine calcium phosphates (Fig.
S1). The data reported in Table 1 indicate that the amount of deposited
PDA increases with immersion time, in agreement with previous studies
[19]. However, the amount of PDA deposited onto αTCP is always
significantly higher than onto OCP, most likely because of the different
morphology of the two calcium phosphates. In fact, SEM images of OCP
and αTCP immersed in dopamine solution for different periods of time
(Fig. S2) confirm the greater amount of the polymer deposited onto
αTCP porous particles than onto OCP flat crystals.
However, PDA onto αTCP appears clustered into aggregates
whereas it seems more spread in close contact with the large surface of
OCP crystals. Moreover, the samples obtained after immersion for 18 h
show a massive dopamine polymerization that occurs without a close
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relationship with the calcium phosphates. On this basis, deposition of
AgNPs was carried out on PDA functionalized samples obtained using
an immersion time of 2 h.
The deposition of PDA provokes also variations in the values of
contact angle and time required for water complete spreading on the
surface, which increase with PDA content (Table 1). This finding is
somewhat opposite to what usually verified in other studies where PDA
deposition induces a decrease of the contact angle with respect to that
of the support [27,28]. However, at variance with the supports used in
those studies, both OCP and αTCP are highly hydrophilic, in agreement
with their low contact angles and water spreading times (Table 1). The
modest increase of the values of these parameters on increasing PDA
could be ascribed to the less homogeneous surfaces of the composite
Fig. 1. XRD patterns of the different samples. The main dif-
fraction peak due to Ag is indicated with (▼). The relative in-
tensity of this reflection increases on increasing the concentra-
tion of the silver nitrate solution.
Fig. 2. SEM images of (a) OCPdAg1, (b) OCPdAg5, (c) OCPdAg10, (d) αTCPdAg1, (e) αTCPdAg5, (f) αTCPdAg10.
Table 1
Polydopamine content (determined through thermogravimetric analysis) of the different
samples as a function of time. The values of contact angles and water absorption time are
also reported.
Substrate Time
(h)
PDA content
(wt%)
Static contact angle
θ (°)
Absorption time
(s)
OCP – – 28 ± 1 2
OCPd 1 < 1 43 ± 2 11
OCPd 2 2.1 ± 0.5 45 ± 2 > 15
OCPd 18 10.4 ± 1.0 65 ± 3 ≫15
αTCP – – 23 ± 2 1
αTCPd 1 2.4 ± 0.5 32 ± 1 1
αTCPd 2 6.5 ± 0.7 53 ± 2 3
αTCPd 18 25.7 ± 2.2 55 ± 2 12
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samples due to the presence of the polymer.
The XRD patterns of the functionalized calcium phosphates after
AgNPs deposition show the characteristic reflections of OCP (PDF 26-
1056) and αTCP (PDF 9-348) respectively, together with a reflection at
about 38.1° of 2θ corresponding to the most intense peak of silver (PDF
4-783) (Fig. 1). The relative intensity of this reflection increases with
the concentration of the AgNO3 solution used for the deposition.
The presence of AgNPs onto the surface of OCPd and αTCPd is
appreciable also in the SEM images of the composite materials. In
particular, AgNPs appear more homogeneously distributed on the OCPd
crystals surfaces than on αTCPd particles (Fig. 2).
The results of ICP investigation reported in Table 2 indicate that the
amount of AgNPs associated to OCPd and αTCPd increases with silver
concentration in solution up to about 11.6 and 6.8 wt%, respectively.
The greater deposition of AgNPs onto OCPd cannot be ascribed to a
greater presence of PDA, since its content (2.1%) its smaller than on
αTCPd (6.5%), and it might be due to the morphology of the big plate-
like crystals of octacalcium phosphate, which favors a more homo-
geneous deposition of PDA, and, as a consequence, of AgNPs.
3.2. In vitro tests
In vitro osteoblast cytotoxicity, viability and differentiation, as well
as antibacterial tests were performed on disk-shaped samples, which
were prepared by pressing the sample powders, as reported in Materials
and methods. The different morphology of OCP and αTCP are still ap-
preciable on the surfaces of the disks, as results from the AFM images
reported in Fig. 3. The mean values of roughness parameters are
Rq = 43 ± 4 nm, Ra = 30 ± 4 nm, Rt = 390 ± 41 nm for OCP,
and Rq = 75 ± 8 nm; Ra = 55 ± 6 nm; Rt = 600 ± 63 nm for
αTCP. No appreciable difference in the roughness parameters has been
determined after AgNPs deposition on both substrates, although the
surface morphology appears less defined (Fig. 3) most likely because of
the presence of PDA, which gives a different interaction with the AFM
probe in comparison with the harder inorganic phases.
Silver release from OCPdAg5 and αTCPdAg5 during in vitro cell tests
was measured in cell culture medium. The cumulative release from
OCPdAg5 and αTCPdAg5 increases with time and reaches values of
3.7 μg/ml and 5.2 μg/ml respectively after 7 days, as shown in Fig. 4.
The amount of silver release is greater from αTCPdAg5 than from
OCPdAg5, most likely due to their different roughness, but it is however
very small,< 1 wt% of the initial content.
The structure and morphology of the disk shaped samples after
7 days immersion in cell medium are compared with those of the
starting samples in Figs. S3 and S4. XRD patterns of OCPdAg5 and
αTCPdAg5 do not show any appreciable modifications after incubation.
However, at variance with OCPdAg5, which does not show any ap-
preciable morphological change, the SEM image of the surface of
Fig. 3. AFM images of the surface of disk-shaped samples used for in-vitro tests.
Table 2
Ag content (wt%) determined through ICP analysis of solid samples obtained after immersion of OCPd and αTCPd into solutions at different concentration of AgNO3.
Samples OCPdAg1 OCPdAg5 OCPdAg10 αTCPdAg1 αTCPdAg5 αTCPdAg10
Ag content
(wt%)
1.6 ± 0.1 8.2 ± 0.2 11.6 ± 0.2 0.8 ± 0.1 4.7 ± 0.1 6.8 ± 0.2
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αTCPdAg5 after immersion displays the presence of small crystals, most
likely due to deposition from the supersaturated medium. It is con-
ceivable to suppose that the amount of deposition is under the detection
limit of XRD technique.
3.2.1. Cell cytotoxicity
MG63 are an osteoblast cell line well characterized and widely used
in in vitro studies. Even if they display some differences in comparison
to primary osteoblast in morphology and proliferation rate, they ex-
press the main markers of osteoblast differentiation useful for in vitro
studies, have the advantage of a standard behaviour and are chosen to
assess biomaterial biocompatibility.
At the end of experimental times, scheduled tests were performed to
analyze cytotoxicity after OB culture with samples of OCP and αTCP at
different AgNPs content. The percentage of viability in comparison to
CTR- (considered as 100%) reported in Fig. 5 shows that all samples
values are lower than CTR-, both at 24 and 72 h of culture
(p < 0.0005). Nevertheless, as a material is considered cytotoxic when
its viability is less than 70% in comparison to CTR-, only samples
OCPdAg10 and αTCPdAg10 may be considered cytotoxic [29]. As ex-
pected, CTR+ was significant lower than all experimental samples and
CTR-. Further analysis of possible cytotoxic effects was performed
through evaluation of LDH, Caspase 3 and IL-6. LDH is an intracellular
enzyme and its detection in the supernatant of cell culture is considered
a sign of cytotoxicity as a consequence of cytoplasmatic membrane
damage [29]. At 24 h significant LDH level was detected only in αT-
CPdAg10 when compared to CTR-. At 72 h OCPdAg10 and all AgNPs
containing αTCP groups were significantly higher than CTR-. CTR+
was significantly different from all groups both at 24 and 72 h.
Apoptosis mechanism, expressed through extrinsic and intrinsic
pathways, involves the activation of Caspase 3 through a cascade re-
action. This protease activity has an essential role in protein degrada-
tion and cell death [30]. Moreover, OB in response to a cytotoxic agent
produce different soluble inflammatory mediators as IL-6, that plays an
Fig. 5. Viability and cytotoxicity tested on OB grown on OCP or αTCP with different concentration of Ag, after 24 or 72 h of culture. Statistical significance: (*p < 0.05; **p < 0.005;
***p < 0.0005):
WST1: ***CTR+ and CTR- vs all experimental samples
LDH: ***CTR+ vs all at both 24 and 72 h; ***OCPAg10 and αTCPdAg10 vs CTR- (72 h); **αTCPdAg5 vs CTR- (72 h); **αTCPdAg10 vs CTR- (24 h); *αTCPdAg1 vs CTR- (72 h)
IL-6: ***CTR+ vs all at both 24 and 72 h; *αTCPdAg10 vs CTR- (24 h)
CASPASE 3: **CTR+ vs all; *αTCPdAg10 vs CTR-.
Fig. 4. Silver ions release from disk-shaped samples of OCPdAg5 and αTCPdAg5 after
incubation in the medium used for cell culture differentiation up to 7 days.
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important role in local regulation of bone turnover [31]. Caspase 3
(72 h) and IL-6 (24 h) were significantly higher than CTR- only in αT-
CPdAg10.
It is worthwhile to notice that AgNPs content of αTCPdAg10 is
lower than that of OCPdAg5 and OCPdAg10, as shown in Table 2. It
follows that the above reported results suggest that the combination of
AgNPs with OCP provides more biocompatible materials than those
obtained using αTCP as substrate.
Representative pictures of cultured cells at 24 h after Neutral Red
staining are showed in Fig. 6. All samples show a significant uptake of
dye, even if they display different cell concentration, In particular, the
cells on OCPdAg10 and αTCPdAg10 display irregular shape, at variance
with the other samples, which exhibit normal cell morphology.
3.2.2. Cell bioactivity
On the basis of the results of the cytotoxicity tests, further in-
vestigation on biocompatibility and bioactivity was performed on
OCPdAg5 and αTCPdAg5, as well as on OCP and αTCP. Both OCP and
αTCP are known to be effective in improving osteoblast activity
[32–37]. The results of cytotoxicity tests indicate that the presence of
AgNPs in OCPdAg5 and αTCPdAg5 should not interfere with cellular
activity, while exerting its local action to prevent bacterial infections
[38].
3.2.2.1. Osteoblast viability. The evaluation of cell proliferation and
viability was performed after 7 days of culture, by Live/Dead staining
and WST1 test (Figs. 7 and 8 respectively). Even if a higher number of
cells was observed onto OCP in comparison to αTCP, pictures of
osteoblasts demonstrated that cells cultured onto biomaterials, with
or without Ag, grew and proliferated regularly, showing a normal
morphology, as confirmed by SEM images, which show cells well
spread and rich of philopodia. Differences on cell number are
appreciable, in agreement with viability and proliferation test (Fig.
S5). Cell adhered to the different substrates and their adhesion was not
affected by the presence of AgNPs (Fig. 7).
These results were confirmed by the analysis of WST1 test: results
showed significant higher values for OCP and OCPdAg5 when com-
pared to both αTCP and αTCPdAg5 (Fig. 8), confirming the different
influence of OCP and αTCP on viability. The viability percentage at 7
days of all groups (OCP 120%, OCPAg5 111%, αTCP 73%, αTCPAg5
78%) resulted higher than 70% in comparison with CTR group (con-
sidered as 100%), demonstrating absence of cytotoxicity [29]. More-
over no differences in viability where found between OCP and
OCPdAg5, and between αTCP and αTCPdAg5.
3.2.2.2. Osteoblast activity and gene expression. To complete the
assessment of the effects of the studied biomaterials on osteoblasts,
the activated Caspase 3, as a key role molecule in the main pathway of
apoptosis [30], was measured. The production of ALP and OSTC was
also measured at 7 days, as they represent common markers of the
activity of differentiated osteoblasts [38]. After 7 days of culture no
difference was found for Caspase 3 neither between materials with or
without AgNPs, nor between materials and CTR (considered equal to 1)
(Fig. 8). Statistical analysis found that Caspase 3 values were inversely
correlated with WST1 data (p < 0.005), and in agreement with Live/
Dead staining. In fact, as a very low number of red dead cells was
observed in all samples (indicated by arrows in Fig. 7), the lower
number of cells on αTCP samples may be related to a lower rate of
proliferation rather than to cell death for apoptosis. Both ALP and OSTC
data after 7 days of culture showed significant differences in
comparison with CTR (normalized to 1, p < 0.05), but no
differences were found among materials (Fig. 8). Results of ALP
activity and OSTC production demonstrated that both OCP and αTCP
stimulated osteoblast activity and differentiation, and that the presence
of AgNPs did not interfere with culture. In particular, the results
obtained on OCP samples fit well with those of a previous in vivo
study [3] that demonstrated that OCP promotes bone regeneration at
the initial bone apposition stage and undergoes rapid biodegradation,
suggesting that OCP and OCPdAg5 should promote fast bone formation
and bioavailability of the antibacterial agent.
The measure of gene expression for the proteins detected in super-
natant by immune-enzymatic assays, namely CASP3, ALPL, and BGLAP
(OSTC), was also performed at the end of experimental time (Fig. 9).
Moreover RUNX2 gene was investigated to verify if osteoblast main-
tained their differentiation [39]. The results, compared to CTR, de-
monstrated that gene expression did not differ from CTR and that there
were no differences among biomaterials for CASP3, ALPL, and RUNX2.
Although no differences were found for OSTC production detected in
culture supernatant, BGLAP expression in OB cultured onto OCP at the
same time point showed a significant higher level in comparison with
αTCP and αTCPdAg5. To conclude the analysis of data, ALPL, BGLAP
and RUNX2 were found to directly correlate (p < 0.005), as a con-
firmation of data consistency.
Fig. 6. Neutral Red staining of OB cultured for 72 h on OCP, αTCP and CTRs. Living cells actively incorporated red dye, and grow adhering to the substrate showing a normal
morphology. Dead cells, as CTR+ image, did not uptake dye, appeared round and detached from the substrate surface.
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Fig. 8. Osteoblast viability and activity after 7 days of culture on OCP, OCPdAg5, αTCP, and αTCPdAg5. (*p < 0.05; **p < 0.005; ***p < 0.0005).
WST1. ***OCP vs αTCP, αTCPdAg5; **OCPdAg5 vs αTCP; *OCPdAg5 vs αTCPdAg5
Fig. 7. Live/dead staining of osteoblast cultured for
7 days on OCP, OCPdAg5, αTCP, and αTCPdAg5. Cells
proliferated regularly onto the surface of all samples
and adhered to the surface of biomaterials, showing
normal morphology. Arrows point out dead red cells.
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3.3. Antibacterial susceptibility testing against bacterial strains
In a preliminary set of experiments, the in vitro antibacterial activity
of OCPd and αTCPd samples loaded with different contents of AgNPs
was determined against three Gram positive (S. aureus, S. epidermidis, E.
faecalis) and three Gram negative (E. coli, K. pneumoniae and P. aeru-
ginosa) reference strains. Results demonstrated that all composite ma-
terials, regardless their AgNPs content, inhibited bacterial growth as a
clear bacterial-free zone was observed around the disks following a
24 h-incubation. In particular, among Gram positive bacteria, the
highest inhibitory activity was displayed against S. epidermidis while the
effectiveness of the compounds was remarkable towards all the Gram
negative bacteria and did not differ among tested strains. Table 3 re-
ports the diameter of the bacterial-free zone around the disk-shaped
samples of OCPdAg5 and αTCPdAg5 (8.2 and 4.7% content of AgNPs).
These materials, which were selected as they demonstrated to be
effective against bacterial growth without cytotoxicity on osteoblast,
were assayed against clinical isolates of S. epidermidis and P. aeruginosa
presenting different antibiotic susceptibilities. In particular, the panel
of samples included methicillin-resistant S. epidermidis (MRSE) and
MDR P. aeruginosa. The antibiotic-resistance profile of each clinical
strain and the antibacterial activities of the composite materials are
reported in Table 4.
Both OCPdAg5 and αTCPdAg5 displayed antibacterial properties
against all the tested clinical isolates and the comparison of the dia-
meters of the inhibition zone indicates a greater activity of OCPdAg5 in
comparison to αTCPdAg5, possibly due to the higher content of AgNPs
(8.2 vs. 4.7%). Notably, these selected biomaterials at this AgNPs
content did not interfere with osteoblast proliferation and activity in-
dicating a specific antibacterial property. Both samples proved to be
effective towards methicillin-sensitive S. epidermidis (MSSE) and MRSE
strains that were resistant to erythromycin or gentamicin or levo-
floxacin or trimethoprim/sulfamethoxazole, in addition to oxacillin and
all other β-lactam and cephalosporin antibiotics that share structural
similarity with methicillin. Of note, tested samples were also active
against two isolates that were resistant to the GMN/IPM reference disk
controls in the KB diffusion method, and that were susceptible only to
tetracycline as determined by EUCAST clinical zone diameter break-
points. Considering the selected P. aeruginosa strains, both OCPdAg5
and αTCPdAg5 showed a remarkable inhibitory property towards both
sensitive and heterogeneous MDR phenotypes.
4. Conclusions
The results of this study indicate that polydopamine can be used as a
tool to trigger the deposition of silver nanoparticles onto calcium
phosphates. The different morphology of OCP and αTCP plays an im-
portant role both on polydopamine functionalization and on AgNPs
deposition. In fact, PDA forms a homogeneous layer on the surface of
the big plate-like OCP crystals and aggregates on the αTCP particles.
The different arrangement of PDA could justify the greater amount of
AgNPs loaded on polydopamine functionalized OCP compared to αTCP
surfaces. Moreover, the two calcium phosphate supports play a key role
on osteoblast behavior towards final composite materials: the amount
of AgNPs that does not give any cytotoxicity is significantly greater on
Table 3
Antibacterial activity: diameter of the inhibition zone (in millimeter) against ATCC re-
ference strains.
Reference strains OCPdAg5 αTCPdAg5 GMN 10 μga
S. aureus ATCC 25923 7 ± 1 7 ± 1 20 ± 1
S. epidermidis ATCC 12228 13 ± 1 11 ± 1 25 ± 1
E. faecalis ATCC 29212 6 ± 1 7 ± 1 12 ± 1
E. coli ATCC 25922 12 ± 1 12 ± 1 19 ± 1
K. pneumoniae ATCC 9591 10 ± 1 9 ± 1 18 ± 1
P. aeruginosa ATCC 27853 12 ± 1 12 ± 1 19 ± 1
All experiments were performed on duplicate, on different days.
a Disks containing gentamicin 10 μg (Oxoid SpA, Italy) were used as positive controls.
Fig. 9. Gene expression of osteoblast cultured for 7 days on OCP, OCPdAg5, αTCP, and αTCPdAg5. (*p < 0.05; **p < 0.005; ***p < 0.0005).
BGLAP. ***OCP vs αTCP, αTCPdAg5 p < 0.0005.
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functionalized OCP (8.2 wt%) than on functionalized αTCP (4.7 wt%).
Up to these AgNPs contents, the developed composite materials provide
suitable supports for osteoblast adhesion, proliferation and differ-
entiation, whereas they display a remarkable antibacterial activity to-
wards the main relevant sensitive and multi-drugs resistant bacteria,
demonstrating good potentiality for the treatment of bone or prosthetic
joint infections.
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